138 related articles for article (PubMed ID: 8058603)
1. Characterization of aerosols of human recombinant deoxyribonuclease I (rhDNase) generated by jet nebulizers.
Cipolla D; Gonda I; Shire SJ
Pharm Res; 1994 Apr; 11(4):491-8. PubMed ID: 8058603
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of two aerosol delivery systems for rhDNase.
Shah PL; Scott SF; Geddes DM; Conway S; Watson A; Nazir T; Carr SB; Wallis C; Marriott C; Hodson ME
Eur Respir J; 1997 Jun; 10(6):1261-6. PubMed ID: 9192926
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group.
Fiel SB; Fuchs HJ; Johnson C; Gonda I; Clark AR
Chest; 1995 Jul; 108(1):153-6. PubMed ID: 7606951
[TBL] [Abstract][Full Text] [Related]
4. Aerosol delivery of recombinant human DNase I: in vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer.
Johnson JC; Waldrep JC; Guo J; Dhand R
Respir Care; 2008 Dec; 53(12):1703-8. PubMed ID: 19025706
[TBL] [Abstract][Full Text] [Related]
5. Effect of nebulizer type and antibiotic concentration on device performance.
Weber A; Morlin G; Cohen M; Williams-Warren J; Ramsey B; Smith A
Pediatr Pulmonol; 1997 Apr; 23(4):249-60. PubMed ID: 9141110
[TBL] [Abstract][Full Text] [Related]
6. Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis.
Geller D; Thipphawong J; Otulana B; Caplan D; Ericson D; Milgram L; Okikawa J; Quan J; Bowman CM
J Aerosol Med; 2003; 16(2):175-82. PubMed ID: 12823911
[TBL] [Abstract][Full Text] [Related]
7. Measuring nebulizer output. Aerosol production vs gravimetric analysis.
Tandon R; McPeck M; Smaldone GC
Chest; 1997 May; 111(5):1361-5. PubMed ID: 9149595
[TBL] [Abstract][Full Text] [Related]
8. Nebulization of PEGylated recombinant human deoxyribonuclease I using vibrating membrane nebulizers: A technical feasibility study.
Mahri S; Wilms T; Hagedorm P; Guichard MJ; Vanvarenberg K; Dumoulin M; Frijlink H; Vanbever R
Eur J Pharm Sci; 2023 Oct; 189():106522. PubMed ID: 37423579
[TBL] [Abstract][Full Text] [Related]
9. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols.
Coates AL; MacNeish CF; Meisner D; Kelemen S; Thibert R; MacDonald J; Vadas E
Chest; 1997 May; 111(5):1206-12. PubMed ID: 9149571
[TBL] [Abstract][Full Text] [Related]
10. Pulse nebulization in pneumatic devices.
Gradoń L; Sosnowski TR; Podolec Z
Int J Occup Saf Ergon; 1999; 5(1):31-42. PubMed ID: 10602637
[TBL] [Abstract][Full Text] [Related]
11. Characterization of aerosol output from various nebulizer/compressor combinations.
Reisner C; Katial RK; Bartelson BB; Buchmeir A; Rosenwasser LJ; Nelson HS
Ann Allergy Asthma Immunol; 2001 May; 86(5):566-74. PubMed ID: 11379809
[TBL] [Abstract][Full Text] [Related]
12. Measurement of particle and mass distribution of pentamidine aerosol by ultrasonic and air jet nebulizers.
Hager J; Gober KH; Löhr JP; Dürr M
J Aerosol Med; 1992; 5(2):65-79. PubMed ID: 10147685
[TBL] [Abstract][Full Text] [Related]
13. Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system.
Bustami RT; Chan HK; Sweeney T; Dehghani F; Foster NR
Pharm Res; 2003 Dec; 20(12):2028-35. PubMed ID: 14725370
[TBL] [Abstract][Full Text] [Related]
14. Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group.
Geller DE; Eigen H; Fiel SB; Clark A; Lamarre AP; Johnson CA; Konstan MW
Pediatr Pulmonol; 1998 Feb; 25(2):83-7. PubMed ID: 9516090
[TBL] [Abstract][Full Text] [Related]
15. Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.
Guichard MJ; Kinoo D; Aubriot AS; Bauwens N; Gougué J; Vermeulen F; Lebecque P; Leal T; Vanbever R
Clin Sci (Lond); 2018 Jul; 132(13):1439-1452. PubMed ID: 29871879
[TBL] [Abstract][Full Text] [Related]
16. Delivery of glucocorticoids by jet nebulization: aerosol characteristics and output.
Leflein J; Brown E; Hill M; Kelly HW; Loffert DT; Nelson HS; Szefler SJ
J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):944-9. PubMed ID: 7751514
[TBL] [Abstract][Full Text] [Related]
17. Effect of Heat Moisture Exchanger on Aerosol Drug Delivery and Airway Resistance in Simulated Ventilator-Dependent Adults Using Jet and Mesh Nebulizers.
Ari A; Dang T; Al Enazi FH; Alqahtani MM; Alkhathami A; Qoutah R; Almamary AS; Fink JB
J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):42-48. PubMed ID: 28829202
[TBL] [Abstract][Full Text] [Related]
18. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.
Chan HK; Clark A; Gonda I; Mumenthaler M; Hsu C
Pharm Res; 1997 Apr; 14(4):431-7. PubMed ID: 9144727
[TBL] [Abstract][Full Text] [Related]
19. Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients.
Awad SM; Berlinski A
Respir Care; 2018 Mar; 63(3):294-300. PubMed ID: 29432139
[TBL] [Abstract][Full Text] [Related]
20. A technical feasibility study of dornase alfa delivery with eFlow® vibrating membrane nebulizers: aerosol characteristics and physicochemical stability.
Scherer T; Geller DE; Owyang L; Tservistas M; Keller M; Boden N; Kesser KC; Shire SJ
J Pharm Sci; 2011 Jan; 100(1):98-109. PubMed ID: 20533437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
